Conclusory statements about how a skilled artisan would combine embodiments in a prior art reference are insufficient to defeat a preliminary injunction.
Agreement to the definition of a term within settlement negotiations may create a binding, enforceable agreement as to that term, despite the absence of a finalized settlement agreement as to all terms.
Stylizing an otherwise generic character mark using ubiquitous lettering does not make it a source identifier.
NATURE SIMULATION SYSTEMS INC. v. AUTODESK, INC.
Before Newman, Lourie, and Dyk. Appeal from the United States District Court for the Northern District of California.
Summary: It was improper for the district court to find patent claims indefinite without considering the specification and prosecution history.
Medtronic announced that its Intellis™ neurostimulator and the Vanta™ neurostimulator have both received approval from the U.S. Food and Drug Administration (FDA) for the treatment of chronic pain associated with diabetic peripheral neuropathy (DPN), in a January 24, 2022 press release. The approval grants patients suffering from DPN access to both products within Medtronic’s spinal cord stimulation (SCS) portfolio. The IntellisTM neurostimulator is rechargeable whereas the VantaTM neurostimulator is recharge-free .
Surgeons at the University of Maryland School of Medicine performed the first successful porcine (pig) to human heart transplant, a procedure referred to as “xenotransplantation.” The patient, 57 year old David Bennett, was recovering and doing well three days after the procedure. The surgical team continues to monitor Mr. Bennett’s condition.
EVOLUSION CONCEPTS, INC. v. HOC EVENTS, INC.
Before Prost, Taranto, and Chen. Appeal from the United States District Court for the Central District of California.
Summary: Claim that requires the removal of a “factory-installed catch bar” before installing “a catch bar” does not imply the preclusion of reuse of the original factory-installed bar.
GE Healthcare announced on December 21, 2021, that it has completed the $1.45 billion acquisition of BK Medical from Altaris Capital Partners. According to the press release, the acquisition expands GE Healthcare’s $3 billion ultrasound business from diagnostics into surgical and therapeutic interventions and adds to GE Healthcare’s capability in the fast-growing advanced surgical visualization segment.
INTEL CORPORATION v. QUALCOMM INCORPORATED
Before Prost, Taranto, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: Indefinite claims do not preclude patentability analysis at the PTAB.
INTEL CORPORATION v. QUALCOMM INCORPORATED
Before Prost, Taranto, and Hughes. Appeal from the Patent Trial and Appeal Board.
Summary: A “generic” motivation to combine that has broad appeal or applicability is not deficient so long as it is supported by more than conclusory expert testimony.
